521 related articles for article (PubMed ID: 30209234)
1. Glial fibrillary acidic protein elevations relate to neuroimaging abnormalities after mild TBI.
Gill J; Latour L; Diaz-Arrastia R; Motamedi V; Turtzo C; Shahim P; Mondello S; DeVoto C; Veras E; Hanlon D; Song L; Jeromin A
Neurology; 2018 Oct; 91(15):e1385-e1389. PubMed ID: 30209234
[TBL] [Abstract][Full Text] [Related]
2. Time course and diagnostic utility of NfL, tau, GFAP, and UCH-L1 in subacute and chronic TBI.
Shahim P; Politis A; van der Merwe A; Moore B; Ekanayake V; Lippa SM; Chou YY; Pham DL; Butman JA; Diaz-Arrastia R; Zetterberg H; Blennow K; Gill JM; Brody DL; Chan L
Neurology; 2020 Aug; 95(6):e623-e636. PubMed ID: 32641529
[TBL] [Abstract][Full Text] [Related]
3. Utility of Acute and Subacute Blood Biomarkers to Assist Diagnosis in CT-Negative Isolated Mild Traumatic Brain Injury.
Reyes J; Spitz G; Major BP; O'Brien WT; Giesler LP; Bain JWP; Xie B; Rosenfeld JV; Law M; Ponsford JL; O'Brien TJ; Shultz SR; Willmott C; Mitra B; McDonald SJ
Neurology; 2023 Nov; 101(20):e1992-e2004. PubMed ID: 37788938
[TBL] [Abstract][Full Text] [Related]
4. Age-Related Differences in Diagnostic Accuracy of Plasma Glial Fibrillary Acidic Protein and Tau for Identifying Acute Intracranial Trauma on Computed Tomography: A TRACK-TBI Study.
Gardner RC; Rubenstein R; Wang KKW; Korley FK; Yue JK; Yuh EL; Mukherje P; Valadka AB; Okonkwo DO; Diaz-Arrastia R; Manley GT
J Neurotrauma; 2018 Oct; 35(20):2341-2350. PubMed ID: 29717620
[TBL] [Abstract][Full Text] [Related]
5. Blood biomarkers on admission in acute traumatic brain injury: Relations to severity, CT findings and care path in the CENTER-TBI study.
Czeiter E; Amrein K; Gravesteijn BY; Lecky F; Menon DK; Mondello S; Newcombe VFJ; Richter S; Steyerberg EW; Vyvere TV; Verheyden J; Xu H; Yang Z; Maas AIR; Wang KKW; Büki A;
EBioMedicine; 2020 Jun; 56():102785. PubMed ID: 32464528
[TBL] [Abstract][Full Text] [Related]
6. Detection of neurofilament-H in serum as a diagnostic tool to predict injury severity in patients who have suffered mild traumatic brain injury.
Gatson JW; Barillas J; Hynan LS; Diaz-Arrastia R; Wolf SE; Minei JP
J Neurosurg; 2014 Nov; 121(5):1232-8. PubMed ID: 25192482
[TBL] [Abstract][Full Text] [Related]
7. Time Course and Diagnostic Accuracy of Glial and Neuronal Blood Biomarkers GFAP and UCH-L1 in a Large Cohort of Trauma Patients With and Without Mild Traumatic Brain Injury.
Papa L; Brophy GM; Welch RD; Lewis LM; Braga CF; Tan CN; Ameli NJ; Lopez MA; Haeussler CA; Mendez Giordano DI; Silvestri S; Giordano P; Weber KD; Hill-Pryor C; Hack DC
JAMA Neurol; 2016 May; 73(5):551-60. PubMed ID: 27018834
[TBL] [Abstract][Full Text] [Related]
8. Acute Effects of Sport-Related Concussion on Serum Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase L1, Total Tau, and Neurofilament Light Measured by a Multiplex Assay.
Asken BM; Yang Z; Xu H; Weber AG; Hayes RL; Bauer RM; DeKosky ST; Jaffee MS; Wang KKW; Clugston JR
J Neurotrauma; 2020 Jul; 37(13):1537-1545. PubMed ID: 32024456
[TBL] [Abstract][Full Text] [Related]
9. Early Levels of Glial Fibrillary Acidic Protein and Neurofilament Light Protein in Predicting the Outcome of Mild Traumatic Brain Injury.
Hossain I; Mohammadian M; Takala RSK; Tenovuo O; Lagerstedt L; Ala-Seppälä H; Frantzén J; van Gils M; Hutchinson P; Katila AJ; Maanpää HR; Menon DK; Newcombe VF; Tallus J; Hrusovsky K; Wilson DH; Blennow K; Sanchez JC; Zetterberg H; Posti JP
J Neurotrauma; 2019 May; 36(10):1551-1560. PubMed ID: 30489229
[TBL] [Abstract][Full Text] [Related]
10. Utility of Serum Biomarkers in the Diagnosis and Stratification of Mild Traumatic Brain Injury.
Lewis LM; Schloemann DT; Papa L; Fucetola RP; Bazarian J; Lindburg M; Welch RD
Acad Emerg Med; 2017 Jun; 24(6):710-720. PubMed ID: 28170122
[TBL] [Abstract][Full Text] [Related]
11. One-Year Prospective Study of Plasma Biomarkers From CNS in Patients With Mild Traumatic Brain Injury.
Clarke GJB; Skandsen T; Zetterberg H; Einarsen CE; Feyling C; Follestad T; Vik A; Blennow K; Håberg AK
Front Neurol; 2021; 12():643743. PubMed ID: 33967940
[No Abstract] [Full Text] [Related]
12. High Levels of NfL, GFAP, TAU, and UCH-L1 as Potential Predictor Biomarkers of Severity and Lethality in Acute COVID-19.
Salvio AL; Fernandes RA; Ferreira HFA; Duarte LA; Gutman EG; Raposo-Vedovi JV; Filho CHFR; da Costa Nunes Pimentel Coelho WL; Passos GF; Andraus MEC; da Costa Gonçalves JP; Cavalcanti MG; Amaro MP; Kader R; de Andrade Medronho R; Figueiredo CP; Amado-Leon LA; Alves-Leon SV
Mol Neurobiol; 2024 Jun; 61(6):3545-3558. PubMed ID: 37996731
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the utility of serum NfL, GFAP, UCHL1 and tTAU as estimates of CSF levels and diagnostic instrument in neuroinflammation and multiple sclerosis.
Koerbel K; Maiworm M; Schaller-Paule M; Schäfer JH; Jakob J; Friedauer L; Steffen F; Bittner S; Foerch C; Yalachkov Y
Mult Scler Relat Disord; 2024 Jul; 87():105644. PubMed ID: 38701697
[TBL] [Abstract][Full Text] [Related]
14. Serum Tau, Neurofilament Light Chain, Glial Fibrillary Acidic Protein, and Ubiquitin Carboxyl-Terminal Hydrolase L1 Are Associated with the Chronic Deterioration of Neurobehavioral Symptoms after Traumatic Brain Injury.
Lange RT; Lippa S; Brickell TA; Gill J; French LM
J Neurotrauma; 2023 Mar; 40(5-6):482-492. PubMed ID: 36170576
[TBL] [Abstract][Full Text] [Related]
15. Association of Blood Biomarkers With Acute Sport-Related Concussion in Collegiate Athletes: Findings From the NCAA and Department of Defense CARE Consortium.
McCrea M; Broglio SP; McAllister TW; Gill J; Giza CC; Huber DL; Harezlak J; Cameron KL; Houston MN; McGinty G; Jackson JC; Guskiewicz K; Mihalik J; Brooks MA; Duma S; Rowson S; Nelson LD; Pasquina P; Meier TB; ; Foroud T; Katz BP; Saykin AJ; Campbell DE; Svoboda SJ; Goldman J; DiFiori J
JAMA Netw Open; 2020 Jan; 3(1):e1919771. PubMed ID: 31977061
[TBL] [Abstract][Full Text] [Related]
16. Plasma neurofilament light chain and glial fibrillary acidic protein predict stroke in CADASIL.
Chen CH; Cheng YW; Chen YF; Tang SC; Jeng JS
J Neuroinflammation; 2020 Apr; 17(1):124. PubMed ID: 32321529
[TBL] [Abstract][Full Text] [Related]
17. The Role of Blood Biomarkers for Magnetic Resonance Imaging Diagnosis of Traumatic Brain Injury.
Yue JK; Upadhyayula PS; Avalos LN; Deng H; Wang KKW
Medicina (Kaunas); 2020 Feb; 56(2):. PubMed ID: 32098419
[No Abstract] [Full Text] [Related]
18. Association between Blood and Computed Tomographic Imaging Biomarkers in a Cohort of Mild Traumatic Brain Injury Patients.
Chen H; Ding VY; Zhu G; Jiang B; Li Y; Boothroyd D; Rezaii PG; Bet AM; Paulino AD; Weber A; Glushakova OY; Hayes RL; Wintermark M
J Neurotrauma; 2022 Oct; 39(19-20):1329-1338. PubMed ID: 35546284
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Utility of Glial Fibrillary Acidic Protein Beyond 12 Hours After Traumatic Brain Injury: A TRACK-TBI Study.
Puccio AM; Yue JK; Korley FK; Okonkwo DO; Diaz-Arrastia R; Yuh EL; Ferguson AR; Mukherjee P; Wang KKW; Taylor SR; Deng H; Markowitz AJ; Sun X; Jain S; Manley GT
J Neurotrauma; 2024 Jun; 41(11-12):1353-1363. PubMed ID: 38251868
[TBL] [Abstract][Full Text] [Related]
20. Blood biomarkers of traumatic brain injury and cognitive impairment in older veterans.
Peltz CB; Kenney K; Gill J; Diaz-Arrastia R; Gardner RC; Yaffe K
Neurology; 2020 Sep; 95(9):e1126-e1133. PubMed ID: 32571850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
